Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma

Item Type:Article
Title:Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma
Creators Name:Elbelt, U. and Trovato, A. and Kloth, M. and Gentz, E. and Finke, R. and Spranger, J. and Galas, D. and Weber, S. and Wolf, C. and Koenig, K. and Arlt, W. and Buettner, R. and May, P. and Allolio, B. and Schneider, J.G.
Abstract:Context: Primary macronodular adrenal hyperplasia (PMAH) is a rare cause of Cushing's syndrome, which may present in the context of different familial multitumor syndromes. Heterozygous inactivating germline mutations of armadillo repeat containing 5 (ARMC5) have very recently been described as cause for sporadic PMAH. Whether this genetic condition also causes familial PMAH in association with other neoplasias is unclear. Objective: The aim of the present study was to delineate the molecular cause in a large family with PMAH and other neoplasias. Patients and Methods: Whole-genome sequencing and comprehensive clinical and biochemical phenotyping was performed in members of a PMAH affected family. Nodules derived from adrenal surgery and pancreatic and meningeal tumor tissue were analyzed for accompanying somatic mutations in the identified target genes. Results: PMAH presenting either as overt or subclinical Cushing's syndrome was accompanied by a heterozygous germline mutation in ARMC5 (p.A110fs*9) located on chromosome 16. Analysis of tumor tissue showed different somatic ARMC5 mutations in adrenal nodules supporting a second hit hypothesis with inactivation of a tumor suppressor gene. A damaging somatic ARMC5 mutation was also found in a concomitant meningioma (p.R502fs) but not in a pancreatic tumor, suggesting biallelic inactivation of ARMC5 as causal also for the intracranial meningioma. Conclusions: Our analysis further confirms inherited inactivating ARMC5 mutations as a cause of familial PMAH and suggests an additional role for the development of concomitant intracranial meningiomas.
Keywords:Adrenal Cortex Diseases, Cushing Syndrome, Germ-Line Mutation, Hyperplasia, Meningeal Neoplasms, Meningioma, Pedigree, Tumor Suppressor Proteins
Source:Journal of Clinical Endocrinology and Metabolism
ISSN:0021-972X
Publisher:Endocrine Society (U.S.A.)
Volume:100
Number:1
Page Range:E119-E128
Date:January 2015
Official Publication:https://doi.org/10.1210/jc.2014-2648
PubMed:View item in PubMed

Repository Staff Only: item control page

Open Access
MDC Library